- Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. Bertot, G.M., Becker, P.D., Guzmán, C.A., Grinstein, S. J. Infect. Dis. (2004)